The Complete Practitioner Guide to Insulin Resistance: Markers, Patterns & Clinical Decision-Making
Jan 21, 2026
Clinical Deep Dive
The Complete Practitioner Guide to Insulin Resistance
Markers, Patterns & Clinical Decision-Making for Functional Practitioners
Insulin resistance sits at the foundation of modern chronic disease. It's the metabolic dysfunction that drives type 2 diabetes, cardiovascular disease, PCOS, fatty liver, and even neurodegenerative conditions. Understanding how to identify it early — and address it systematically — is one of the most valuable skills a functional practitioner can develop.
This guide covers everything you need to know: the physiology, the markers, the patterns, and the clinical reasoning that separates effective practitioners from those who miss the forest for the trees.
Terrain Philosophy: "Stabilizing blood sugar is the single most effective way to lower systemic inflammation and balance hormones." Insulin resistance isn't just a blood sugar problem — it's the upstream driver of dysfunction across virtually every system.
Why Insulin Resistance Is a Tier 1 Priority
In the Three-Tier Decision Tree framework, blood sugar and metabolic function sit at the top — Tier 1. This isn't arbitrary. It reflects the physiological reality that dysglycemia creates cascading dysfunction throughout the body.
Tier 1: Blood Sugar / Metabolic Foundation
Address FIRST, before Tier 2 (Nutrients & Stress) or Tier 3 (Inflammation & Immune). Why? Because you cannot effectively address downstream inflammation or hormonal imbalance if the metabolic terrain is unstable.
When insulin resistance is present, it drives systemic inflammation through multiple pathways, depletes nutrients (B vitamins, magnesium, zinc), disrupts thyroid conversion, creates hormonal imbalances (elevated androgens, estrogen dominance), and damages the liver. Attempting to address these downstream issues without first stabilizing the metabolic foundation is like mopping the floor while the faucet is still running.
The Physiology: What's Actually Happening
Insulin's primary job is to help glucose enter cells for energy production. When cells become resistant to insulin's signal — often due to chronic overconsumption of refined carbohydrates, sedentary lifestyle, chronic stress, or inflammation — the pancreas compensates by producing more insulin.
This compensatory hyperinsulinemia keeps blood glucose in the "normal" range, which is why fasting glucose is one of the last markers to become abnormal. The body will sacrifice nearly everything to maintain glucose homeostasis. By the time fasting glucose rises above 100 mg/dL, the metabolic dysfunction has typically been present for 10-15 years.
Clinical Pearl
Think of insulin resistance as a spectrum, not a binary. Your clients don't wake up one day with diabetes — they progress through years of compensated insulin resistance, then decompensated resistance, then prediabetes, then diabetes. The earlier you catch it, the easier it is to reverse.
The Essential Markers
Fasting Insulin — The Earliest Warning
Conventional: 2-25 μIU/mL
Functional Optimal: 2-6 μIU/mL
This is your canary in the coal mine. A fasting insulin of 12-15 with "normal" glucose means the body is working overtime to maintain homeostasis. Most conventional providers don't order this marker — which is exactly why early insulin resistance goes undetected.
Fasting Glucose — Context Matters
Conventional: 70-99 mg/dL
Functional Optimal: 80-89 mg/dL
A fasting glucose of 95 is "normal" conventionally but already indicates metabolic stress. Combined with elevated insulin, it tells a clear story. In isolation, it tells you very little.
HbA1c — The 3-Month Average
Conventional: <5.7%
Functional Optimal: 4.8-5.3%
HbA1c reflects average glucose over 2-3 months. An HbA1c of 5.5% is "normal" but already trending toward dysfunction. Note: HbA1c can be falsely low with conditions that shorten RBC lifespan (hemolysis, blood loss) or falsely high with conditions that extend it (iron deficiency, B12 deficiency).
HOMA-IR — The Calculated Index
Formula: (Glucose × Insulin) ÷ 405
Optimal: <1.0
HOMA-IR combines glucose and insulin into a single insulin resistance index. Above 1.0 suggests early resistance. Above 2.0 indicates significant resistance. Above 3.0 is established insulin resistance with high diabetes risk.
Triglyceride-to-HDL Ratio — The Lipid Clue
Optimal: <2.0
High Risk: >3.5
This is the best surrogate marker for insulin resistance on a standard lipid panel. A TG:HDL ratio above 3.5 strongly correlates with small dense LDL pattern and atherogenic dyslipidemia — the lipid signature of insulin resistance.
C-Peptide — Pancreatic Output
Conventional: 1.1-4.4 ng/mL
Functional Optimal: 1.0-2.1 ng/mL
C-Peptide is released 1:1 with insulin and reflects endogenous insulin production. Elevated C-Peptide with high glucose = insulin resistance. Low C-Peptide with high glucose = beta cell failure (REFER).
Pattern Recognition: The Five Stages
⚠️ Safety Red Flag — Beta Cell Dysfunction
If you see elevated glucose (>100) with LOW insulin (<5) and low C-Peptide (<1.0), this suggests the pancreas is failing to produce adequate insulin. This is NOT typical insulin resistance — this client needs medical evaluation for possible LADA or progressed Type 2 with beta cell burnout.
Case Study: The "Normal" Labs
38-Year-Old Female — Fatigue, Weight Gain, Brain Fog
Chief Complaints: Can't lose weight despite "eating healthy," exhausted by 3pm, brain fog during afternoon meetings, wakes up at 2-3am, irritable before meals.
Lab Results:
Fasting Glucose: 96 mg/dL — Conventionally "normal," functionally elevated
HbA1c: 5.5% — Conventionally "normal," functionally above optimal
Fasting Insulin: 14 μIU/mL — Conventionally "normal," functionally elevated (2.3x upper optimal)
HOMA-IR: 3.3 — Not routinely calculated, clearly indicates established resistance
Triglycerides: 145 mg/dL — Conventionally "normal," functionally elevated
HDL: 44 mg/dL — Conventionally "normal," functionally low
TG:HDL Ratio: 3.3 — High risk for small dense LDL pattern
The Pattern: Every single marker is "normal" by conventional standards. Her doctor told her labs were fine. But the pattern is unmistakably established insulin resistance — likely present for 5+ years.
Tier 1 Focus: This is a Tier 1 priority. Address blood sugar regulation FIRST before investigating thyroid, adrenals, or other systems. Many of her symptoms (fatigue, brain fog, 2-3am waking) are likely downstream effects of dysglycemia.
Clinical Pearl
The 2-3am waking is a classic sign of reactive hypoglycemia. Blood sugar drops during the night, triggering a cortisol surge to mobilize glucose. The cortisol wakes her up. This often resolves completely when blood sugar is stabilized — without any adrenal supplementation.
Downstream Effects: Why This Matters Beyond Blood Sugar
Insulin resistance doesn't stay contained to glucose metabolism. It creates ripple effects across virtually every system:
Systemic Effects of Insulin Resistance
→ Inflammation: Elevated insulin drives inflammatory cytokine production, elevating hs-CRP
→ Thyroid: Insulin resistance impairs T4 to T3 conversion and increases reverse T3
→ Sex Hormones: Elevated insulin increases ovarian androgen production (PCOS) and reduces SHBG
→ Liver: Drives hepatic lipogenesis, leading to NAFLD and elevated liver enzymes
→ Cardiovascular: Creates atherogenic dyslipidemia (high TG, low HDL, small dense LDL)
→ Nutrients: Depletes magnesium, B vitamins, zinc, and chromium
This is why the Three-Tier framework places blood sugar at Tier 1. You can spend months chasing thyroid dysfunction, hormonal imbalance, or chronic inflammation — but if the underlying insulin resistance isn't addressed, you're treating symptoms, not causes.
Intervention Framework
Once insulin resistance is identified, intervention focuses on improving insulin sensitivity through diet, lifestyle, and targeted support. The good news: insulin resistance is highly reversible when caught early.
Core Lifestyle Interventions
→ Reduce refined carbohydrates: Especially liquid sugars, processed grains, high-glycemic foods
→ Protein at every meal: 25-40g protein per meal stabilizes glucose response
→ Healthy fats: Replace refined carbs with olive oil, avocado, nuts, fatty fish
→ Strength training: Builds glucose-absorbing muscle; most effective for insulin sensitivity
→ Post-meal walking: 10-15 minutes after meals significantly blunts glucose spikes
→ Sleep optimization: Sleep deprivation directly impairs insulin sensitivity
→ Stress management: Chronic cortisol elevation drives glucose dysregulation
Targeted Nutritional Support (Scope-Safe)
→ Chromium: Enhances insulin receptor sensitivity
→ Magnesium: Cofactor for glucose metabolism; often depleted in IR
→ Alpha-lipoic acid: Improves glucose uptake and provides antioxidant support
→ Berberine: Activates AMPK; comparable to metformin (check drug interactions)
→ Omega-3 fatty acids: Reduce inflammation and improve lipid profile
→ Fiber: Slows glucose absorption and supports gut microbiome
Clinical Pearl
If a client is on metformin, always assess B12 status. Metformin depletes B12 over time, and many symptoms attributed to "diabetes" (neuropathy, fatigue, cognitive issues) may actually be B12 deficiency.
Monitoring Progress
Retest metabolic markers at 12 weeks. Expect to see fasting insulin drop first, followed by improvements in TG:HDL ratio, then glucose and HbA1c. Clients who implement the lifestyle changes consistently often see dramatic improvements — fasting insulin dropping from 15 to 6, HOMA-IR normalizing, and TG:HDL ratio falling below 2.0.
If markers don't improve despite reported compliance, investigate hidden sources of glucose dysregulation: sleep apnea, chronic infection, undisclosed dietary lapses, or medication effects (corticosteroids, certain antipsychotics).
Summary: The Tier 1 Imperative
Insulin resistance is the metabolic foundation that supports — or undermines — everything else. When you identify it early using fasting insulin, HOMA-IR, and TG:HDL ratio, you catch dysfunction years before conventional testing would flag it. When you address it systematically as a Tier 1 priority, you often see downstream issues (inflammation, hormonal imbalance, thyroid dysfunction) improve without direct intervention.
This is the power of the terrain-based approach: stabilize the foundation, and the body's innate healing capacity can address much of the rest.
Master Functional Blood Chemistry
Learn the complete Three-Tier Decision Tree framework, pattern recognition skills, and clinical reasoning in our comprehensive MTAOFBC course.
